Abstract:Epstein-Barr virus (EBV) is associated with several types of human cancer including nasopharyngeal carcinoma (NPC). The activation of EBV to the lytic cycle has been observed in advanced NPC and is believed to contribute to late-stage NPC development. However, how EBV lytic cycle promotes NPC progression remains elusive. Analysis of clinical NPC samples indicated that EBV reactivation and immunosuppression were found in advanced NPC samples, as well as abnormal angiogenesis and invasiveness. To investigate the role of the EBV lytic cycle in tumor development, we established a system that consists of two NPC cell lines, respectively, in EBV abortive lytic cycle and latency. In a comparative analysis using this system, we found that the NPC cell line in EBV abortive lytic cycle exhibited the superior chemotactic capacity to recruit monocytes and polarized their differentiation toward tumor-associated macrophage (TAM)-like phenotype and away from DCs, compared to EBV-negative or EBV-latency NPC cells. EBV-encoded transcription activator ZTA is responsible for regulating monocyte chemotaxis and TAM phenotype by up-regulating the expression of GM-CSF, IL-8, and GRO-α. As a result, TAM induced by EBV abortive lytic cycle promotes NPC angiogenesis, invasion, and migration. Overall, this study elucidated the role of the EBV lytic life cycle in the late development of NPC and revealed a mechanism underlying the ZTA-mediated establishment of the tumor microenvironment (TME) that promotes NPC late-stage progression. Recently increasing evidence suggests that the lytic life cycle of certain oncoviruses contributes to tumorigenesis. This is in contrary to traditional wisdom that virally associated tumors are mainly attributed to the latent cycle of a tumor virus but not to the lytic phase simply because a lytic virus in general leads to lysis and death of host cells. However, the paradoxical roles of viral lytic cycle in tumorigenesis are still elusive. In the current study, we investigated the role of the EBV lytic cycle in NPC development. With a breakthrough in methodology that allows us to establish an EBV abortive lytic phase cell model, we compared the NPC cells in latent and abortive lytic phase respectively and found that the NPC cells in EBV abortive lytic cycle exhibited the superior chemotactic capacity to recruit monocytes and polarized their differentiation toward TAM-like phenotype and away from DCs. As a consequence, TAM induced by EBV abortive lytic cycle promotes NPC angiogenesis, invasion, and migration. Our study revealed the role of EBV lytic life cycle in NPC development that regulates monocytes to create a tumor-promoting microenvironment and possible implications for novel therapeutic strategy to treat NPC late-stage patients.

Vasculogenic Mimicry Formation in EBV-associated Epithelial Malignancies

The progress of virus-targeted new therapy against Epstein-Barr virus-associated malignancies

EBV-associated epithelial cancers cells promote vasculogenic mimicry formation via a secretory cross-talk with the immune microenvironment

Epstein-Barr Virus Induces Lymphangiogenesis and Lympth Node Metastasis via Upregulation of VEGF-C in Nasopharyngeal Carcinoma

Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103

Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1α-VEGF pathway

Targeting exosomes enveloped EBV‐miR‐BART1‐5p‐antagomiRs for NPC therapy through both anti‐vasculogenic mimicry and anti‐angiogenesis

New insights into Epstein-Barr virus-associated tumors: Exosomes

Exosomal HMGA2 protein from EBV-positive NPC cells destroys vascular endothelial barriers and induces endothelial-to-mesenchymal transition to promote metastasis

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry

EBV-positive glycoproteins associated with nasopharyngeal carcinoma

The immune escape mechanism of nasopharyngeal carcinoma

Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas

Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma

EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation

EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation

The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma

The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies

Epstein-Barr viral product-containing exosome facilitates LIF-associated immunosuppressive polarization of macrophage in nasopharyngeal carcinoma

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma

Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer